Navigation Links
Demystifying a Common, Persistent Virus
Date:4/1/2010

Researchers think they know how cytomegalovirus continues to re-infect people

THURSDAY, April 1 (HealthDay News) -- New research sheds light on how a virus known as cytomegalovirus (CMV), which infects up to 80 percent of the U.S. population before age 40, re-infects people again and again even though their immune systems strongly respond to it.

The infection doesn't always make people ill, but certain people, such as newborns and others with weakened immune systems, can develop serious symptoms and disabilities.

"CMV is one of a few virus types that can efficiently re-infect individuals who are already persistently infected by this virus," Dr. Louis Picker, an associate director of Oregon Health & Science University's Vaccine and Gene Therapy Institute, said in a news release.

"When most viruses infect a host, the immune system remembers the disease and protects against re-infection. This is the case with smallpox, seasonal strains of flu and several other viruses," Picker said. "This immune system reaction is also the reason why vaccines made with weakened or dead viruses work against these pathogens. In the case of CMV, the body's immune system is continuously stimulated by ongoing, low-level persistent infection, but yet CMV is still able to re-infect. This research explains how CMV is able to overcome this immune response so that re-infection occurs."

Picker and colleagues studied monkeys infected with CMV and found that the disease is able to overcome a "crucial immune barrier," Klaus Frueh, a senior scientist at the institute, said in the university news release.

The researchers, who report their findings online April 1 in the journal Science, say the study shows that it will be difficult to create a vaccine to combat the virus. On the other hand, modified bits of the virus could serve to carry vaccines into the body, and the research may help in the development of other v
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved

Page: 1 2

Related medicine news :

1. Complications common, often linked to trauma in children receiving cochlear implants
2. H1N1 Virus Yields Up More Secrets
3. FDA Asks Docs to Suspend Using Glaxo Rotavirus Vaccine
4. GlaxoSmithKline Statement on New Information Relating to Manufacture of Rotarix (Rotavirus Vaccine)
5. Reovirus may be a novel approach to prostate cancer treatment
6. Infectious Virus Hides In Human Chromosomes During Latency And Can Be Passed From Parents To Their Children
7. Researchers find further evidence linking Epstein-Barr virus and risk of multiple sclerosis
8. New Study: Improved Immune System with Gene-Eden, a Natural Antiviral Supplement that Targets Chronic Viruses
9. Virus Unlikely to Cause Chronic Fatigue Syndrome
10. Chronic Fatigue Syndrome-Virus Link Questioned
11. Researchers find broad spectrum antiviral that fights multitude of viruses
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2014)... By Kathleen Doheny ... (HealthDay News) -- Birth control pills containing high doses ... the risk of breast cancer in women under 50, ... oral contraceptive formulations," explained lead researcher Elisabeth Beaber, a ... in Seattle. "Some of these formulations increase breast cancer ...
(Date:8/1/2014)... Roaming the high Alps more than 5,000 years ago, ... Man" no doubt had a very tough and active lifestyle. ... the Ice Man, nicknamed Otzi, from a very modern scourge: ... "hardening of the arteries," appears to be the same today ... finds. "Our ancestors going back thousands of years ...
(Date:8/1/2014)... The European gas chromatography systems report defines ... forecast of revenue. The gas chromatography systems market in Europe ... to grow to around $247.6 million by 2018, at a ... the TOC of the European gas chromatography systems market, to ... provides a glimpse of the segmentation of gas chromatography systems ...
(Date:8/1/2014)... to a new market research report of "Thermocouples and ... (Automotive, Petrochemical, Consumer Utility, Glass, and Aerospace & Defense) ... & Forecast to 2010 - 2020", published by MarketsandMarkets, ... Billion by 2020 at a CAGR of 3.70% and ... $238.17 Million by 2020 at a CAGR of 13.81% ...
(Date:8/1/2014)... The Gerontological Society of America (GSA) ... the field of aging has chosen J. ... 2014 recipient of the Distinguished Career Contribution to ... annually to an individual whose theoretical contributions have ... or have yielded original and elegant research designs ...
Breaking Medicine News(10 mins):Health News:Some Birth Control Pills May Up Breast Cancer Risk 2Health News:Some Birth Control Pills May Up Breast Cancer Risk 3Health News:'Ice Man' Mummy May Have Been at Risk of Heart Disease 2Health News:European Gas Chromatography (GC) Systems Market is Expected to Reach $247.6 Million in 2018 - New Report by MicroMarket Monitor 2Health News:European Gas Chromatography (GC) Systems Market is Expected to Reach $247.6 Million in 2018 - New Report by MicroMarket Monitor 3Health News:European Gas Chromatography (GC) Systems Market is Expected to Reach $247.6 Million in 2018 - New Report by MicroMarket Monitor 4Health News:Thermocouples Market worth $1.42 Billion & High End Optical Pyrometers Market worth $ 238.17 Million by 2020 2Health News:Thermocouples Market worth $1.42 Billion & High End Optical Pyrometers Market worth $ 238.17 Million by 2020 3Health News:Thermocouples Market worth $1.42 Billion & High End Optical Pyrometers Market worth $ 238.17 Million by 2020 4Health News:Suitor to receive GSA's 2014 Distinguished Career Contribution to Gerontology Award 2
... VIEW, Calif., Nov. 20 Omnicell, Inc. (Nasdaq: OMCL ) a ... company will present at the 21st Annual Piper Jaffray Healthcare Conference ... , Omnicell Speakers: Randall A. Lipps, founder, chairman, president & ... Tuesday, December 1, 2009 , Time: 1:00 p.m. EST , ...
... , NEW YORK, Nov. 20 Today, ... announce the launch of a capsule gift giving collection offered exclusively ... is inspired by and designed for St. Jude,s Children,s Research Hospital,s ... program which encourages consumers to "give thanks for the healthy kids ...
... DEL REY, Calif., Nov. 20 Heritage Provider Network, and its ... November 6, 2009, Lakeside Medical Systems, Inc., as well as all ... of the HPN family. , "We first and foremost want to ... are dedicated to maintaining the high level of care they are ...
... ... the national healthcare network, to deliver multispecialty physicians for locum tenens (temporary substitute) ... ... Healthcare is pleased to announce its agreement with VHA Inc., the national healthcare ...
... , NEW ... new market research report is available in its ... Market Review , http://www.reportlinker.com/p0164325/Imaging-Agents---A-Worldwide-Market-Review.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=prnewswire ... visualization of organs within the human body. With ...
... , Carrying and Lifting Tips to Keep you Injury-free this ... travelers have a saying - " Pack your bags, then take out ... bring much more than we need on our trips. Now, even ... are charging passengers a fee for checking luggage . However, ...
Cached Medicine News:Health News:Omnicell to Present at Piper Jaffray Healthcare Conference 2Health News:DKNY JEANS Launches Exclusive Collection With HSN for St. Jude Children's Research Hospital's Thanks and Giving(R) Campaign 2Health News:DKNY JEANS Launches Exclusive Collection With HSN for St. Jude Children's Research Hospital's Thanks and Giving(R) Campaign 3Health News:Heritage Provider Network CEO Dr. Richard Merkin, Announces the Acquisition of Lakeside Medical Systems, Inc. 2Health News:Heritage Provider Network CEO Dr. Richard Merkin, Announces the Acquisition of Lakeside Medical Systems, Inc. 3Health News:VHA Names Jackson Healthcare as Preferred Physician Staffing Vendor 2Health News:VHA Names Jackson Healthcare as Preferred Physician Staffing Vendor 3Health News:Reportlinker Adds Imaging Agents - A Worldwide Market Review 2Health News:Reportlinker Adds Imaging Agents - A Worldwide Market Review 3Health News:Reportlinker Adds Imaging Agents - A Worldwide Market Review 4Health News:Reportlinker Adds Imaging Agents - A Worldwide Market Review 5Health News:Reportlinker Adds Imaging Agents - A Worldwide Market Review 6Health News:Reportlinker Adds Imaging Agents - A Worldwide Market Review 7Health News:Reportlinker Adds Imaging Agents - A Worldwide Market Review 8Health News:Reportlinker Adds Imaging Agents - A Worldwide Market Review 9Health News:This Thanksgiving, Lug your Luggage Safely 2Health News:This Thanksgiving, Lug your Luggage Safely 3
(Date:7/31/2014)...  Cepheid (NASDAQ: CPHD ) today announced that ... invited investors to participate via webcast. ... NY Wednesday, August 13, 2014 at 9.10 a.m. ... New York, NY Thursday, September 4, 2014 ... Webcasts To access the live webcasts for these events, please ...
(Date:7/31/2014)... , July 31, 2014 Rock Creek ... that it has initiated the development of its lead ... and that it has selected Quotient Clinical, The Translational ... (UK) to run its early development programs. ... Trial Application (CTA) by the end of the third ...
(Date:7/31/2014)... , July 31, 2014 Lazarus Effect, a ... interventional devices to facilitate removal of blood clots, announced ... the financing will support EU commercialization of several approved ... the Lazarus ReCover™ and Lazarus Cover™ in ... reflects investor confidence in the value of our novel, ...
Breaking Medicine Technology:Cepheid to Webcast Upcoming Financial Presentations 2Rock Creek Pharmaceuticals Provides Update of its European Drug Development Regulatory Strategy and selects Quotient Clinical for its early development programs 2Rock Creek Pharmaceuticals Provides Update of its European Drug Development Regulatory Strategy and selects Quotient Clinical for its early development programs 3Rock Creek Pharmaceuticals Provides Update of its European Drug Development Regulatory Strategy and selects Quotient Clinical for its early development programs 4Lazarus Effect Closes $5 Million Financing 2
... SAN DIEGO, Jan. 31 TargeGen, Inc. ... multi-center Phase I/II clinical trial of,TG101348, an ... JAK2 in,patients with myeloproliferative diseases., (Logo: ... of JAK2 is implicated in the pathogenesis ...
... Mayo clinic in key role in treatment discovery, ... New York,based company Cytopia Limited (ASX: CYT) announced ... demonstrated potent activity in cells,isolated from patients with ... of diseases where there is over-production of,particular cells ...
Cached Medicine Technology:TargeGen Announces Initiation of Clinical Trial of JAK2 Inhibitor TG101348 in Myeloproliferative Disease Patients 2JAK2 Inhibitor Shows Potent Activity in Cells From MPD Patients 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: